Prefilled syringe fill / finish services market is projected to grow at an annualized rate of over 10% / till 2030

Roots Analysis has done a detailed study on Prefilled Syringe Fill / Finish Services Market, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 260+ page report, which features 60+ figures and 110+ tables, please visit this https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html

Key Market Insights

§  Over 100 companies across the globe claim to provide contract fill / finish services for prefilled syringes; close to 50% of these service providers are large companies with over 500 employees.

§  The market landscape features the presence of well- established players in the domain, most of which claim to operate at various scales of operation and are located in different geographies.

§  In order to acquire competencies across the supply chain and cater to the evolving needs of clients, companies offering services across different scales of operation have established presence in various geographies.

§  Fill / finish service providers are actively investing in expansion projects to upgrade existing capabilities and capacity; several partnerships, mostly focused on offering contract services, have also been forged.

§  As expected, majority of the installed contract fill / finish capacity for prefilled syringes belongs to the large service providers, accounting for around 80% of the available global capacity.

§  The demand for fill / finish services for prefilled syringes is likely to steadily increase in the coming years; we believe stakeholders may have to expand their respective capacities to ensure a consistent supply.

§  An evaluation of prefilled syringe combination product developers revealed that Europe and North America have emerged as the key regions for partnering opportunities for fill / finish service providers.

§  Caste Study: Around 70 prefilled syringes are being manufactured by large companies, most of  which claim to be capable of fabricating syringe barrels from both glass and plastic materials.

§  We expect drug developers to continue to outsource their fill / finish operations in the short to mid term, resulting in an annualized growth at the rate of over 8% within the contract services market.

§  In the long-term, the projected opportunity for the fill / finish service providers for prefilled syringes is likely to be well distributed across various types of barrel chambers, scales of operation and geographical regions.

For more information, please visit https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html

Table of Contents

1.         PREFACE
1.1.       Chapter Overview

1.2.       Scope of the Report

1.3.       Research Methodology

1.4.       Chapter Outlines

2.         EXECUTIVE SUMMARY

3.         INTRODUCTION

3.1.       Chapter Overview

3.2.       Introduction to Prefilled Syringes

3.2.1.    Classification of Prefilled Syringes

3.2.2.    Manufacturing of Prefilled Syringes

3.2.3.    Advantages of Prefilled Syringes

3.2.3.1. Benefits to Healthcare Professionals and End Users

3.2.3.2. Benefits to Manufacturers

3.3.       Fill / Finish Processing of Prefilled Syringes

3.3.1.    Steps Involved in Fill / Finish Process

3.3.2.    Methods of Filling and Stoppering of Prefilled Syringes

3.3.3.    Prefilled Syringe Filling Technologies

3.4.       Factors Contributing to the Growth of Prefilled Syringe Fill / Finish Market

3.5.       Need for Outsourcing Fill / Finish Operations of Sterile Injectables

3.6.       Advantages of Outsourcing Fill / Finish Services

3.7.       Risks Associated with Outsourcing of Fill / Finish Operations

3.8.       Key Considerations While Selecting a Fill / Finish Service Provider

4.         MARKET LANDSCAPE

4.1.       Chapter Overview

4.2.       Prefilled Syringe Fill / Finish Service Providers: Overall Market Landscape

4.2.1.    Analysis by Year of Establishment

4.2.2.    Analysis by Company Size

4.2.3.    Analysis by Scale of Operation

4.2.4.    Analysis by Location of Headquarters

4.2.5.    Analysis by Location of Prefilled Syringe Fill / Finish  Facilities

4.2.6.    Analysis by Type of Drug Molecule

4.2.7.    Analysis by Syringe Barrel Material

4.2.8.    Analysis by Syringe Fill Volume

4.2.9.    Analysis by Additional Services Offered

4.2.10.  Heat Map: Analysis by Company Size and Location of Headquarters

4.2.11.  Logo Landscape: Analysis by Company Size and Type of Drug Molecule

4.2.12.  Geographical Map: Analysis by Scale of Operation and Location of Fill / Finish Facilities

4.2.13.  Grid Representation: Distribution by Year of Establishment, Company Size and Type of Drug Molecule

5.         PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES

5.1.       Chapter Overview

5.2.       Ajinomoto Bio-Pharma Services

5.2.1.    Company  Overview

5.2.2.    Recent Developments and Future Outlook

5.3.       AMRI

5.3.1.    Company  Overview

5.3.2.    Recent Developments and Future Outlook

5.4.       BioPharma Solutions

5.4.1.    Company  Overview

5.4.2.    Recent Developments and Future Outlook

5.5.       Emergent BioSolutions

5.5.1.    Company  Overview

5.5.2.    Recent Developments and Future Outlook

5.6.       Patheon (a  Thermo Fisher Scientific Company)

5.6.1.    Company  Overview

5.6.2.    Recent Developments and Future Outlook

6.         PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN EUROPE: COMPANY PROFILES

6.1.       Chapter Overview

6.2.       Consort Medical

6.2.1.    Company  Overview

6.2.2.    Recent Developments and Future Outlook

6.3.       EVER Pharma

6.3.1.    Company  Overview

6.3.2.    Recent Developments and Future Outlook

6.4.       GlaxoSmithKline

6.4.1.    Company  Overview

6.4.2.    Recent Developments and Future Outlook

6.5.       IDT Biologika

6.5.1.    Company  Overview

6.5.2.    Recent Developments and Future Outlook

6.6.       Rentschler Biopharma

6.6.1.    Company  Overview

6.6.2.    Recent Developments and Future Outlook

6.7.       Siegfried

6.7.1.    Company  Overview

6.7.2.    Recent Developments and Future Outlook

6.8.       Vetter Pharma

6.8.1.    Company  Overview

6.8.2.    Recent Developments and Future Outlook

7.         PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES

7.1.       Chapter Overview

7.2.       Biocon

7.2.1.    Company  Overview

7.2.2.    Recent Developments and Future Outlook

7.3.       Intas Pharmaceuticals

7.3.1.    Company  Overview

7.3.2.    Recent Developments and Future Outlook

7.4.       Kemwell Biopharma

7.4.1.    Company  Overview

7.4.2.    Recent Developments and Future Outlook

7.5.       Square Pharmaceuticals

7.5.1.    Company  Overview

7.5.2.    Recent Developments and Future Outlook

8.         PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS: RECENT DEVELOPMENTS

8.1.       Chapter Overview

8.2.       List of Expansions

8.2.1.    Analysis by Year of Expansion

8.2.2.    Analysis by Type of Expansion

8.2.3.    Analysis by Expanded Scale of Operation

8.2.4.    Analysis by Location of Expansion Project

8.2.5.    Analysis by Type of Drug Molecule Involved

8.2.6.    Analysis by Additional Services Offered (Expansion Specific)

8.3.       Partnership Models

8.4.       List of Partnerships and Collaborations

8.4.1.    Analysis by Year of Partnership

8.4.2.    Analysis by Type of Partnership

8.4.3.    Analysis by Scale of Operation (Deal Specific)

8.4.4.    Analysis by Additional Services Offered (Deal Specific)

9.         CAPACITY ANALYSIS

9.1.       Chapter Overview

9.2.       Assumptions and Methodology

9.3.       Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units)

9.3.1.    Analysis by Company Size

9.3.2.    Analysis by Scale of Operation

9.3.3.    Analysis by Location of Headquarters

9.3.4.    Analysis by Location of Fill / Finish Facilities

9.3.5.    Analysis by Type of Drug Molecule

9.4.       Global, Prefilled Syringe Fill / Finish Capacity (by Volume)

9.4.1.    Analysis by Company Size (Manufacturer)

9.4.2.    Analysis by Scale of Operation

9.4.3.    Analysis by Location of Headquarters

9.4.4.    Analysis by Location of Fill / Finish Facilities

9.4.5.    Analysis by Type of Drug Molecule

10.        DEMAND ANALYSIS

10.1.     Chapter Overview

10.2.     Assumptions and Methodology

10.3.     Global Demand for Prefilled Syringes Fill / Finish Services

10.3.1.  Global Demand for Commercialized Prefilled Syringes Fill / Finish Services

10.3.1.1. Analysis by Geography

10.3.1.1.1. North America

10.3.1.1.2. Europe

10.3.1.1.3. Asia-Pacific

10.3.1.1.4. Latin America

10.3.1.1.5. Middle East and Africa

10.3.1.2. Analysis by Syringe Barrel Material

10.3.1.3. Analysis by Number of Barrel Chambers

10.3.1.4. Analysis by Type of Drug Molecule

10.3.1.5. Analysis by Therapeutic Area

10.3.1.6. Analysis by Specialty Syringes

10.3.2.  Global Demand for Clinical Prefilled Syringes Fill / Finish Services

10.4.     Demand and Supply Analysis

10.4.1.  Demand and Supply Analysis (Scenario 1)

10.4.2.  Demand and Supply Analysis (Scenario 2)

10.4.3.  Demand and Supply Analysis (Scenario 3)

11.        GEOGRAPHICAL ASSESSMENT OF DEMAND AND SUPPLY

11.1.     Chapter Overview

11.2.     Assumptions and Key Parameters

11.3.     Demand and Supply Assessment in North America

11.3.1.  Key Geographies

11.3.1.1. US

11.4.     Demand and Supply Assessment in Europe

11.4.1.  Key Geographies

11.4.1.1. France

11.4.1.2. Germany

11.4.1.3. Italy

11.5.     Demand and Supply Assessment in Asia-Pacific Region

11.5.1.  Key Geographies

11.5.1.1. India

11.5.1.2. Japan

12.        LIKELY PARTNER ANALYSIS

12.1.     Chapter Overview

12.2.     Methodology and Key Parameters

12.3.     Likely Partner Analysis

12.3.1.  Opportunities in North America

12.3.1.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers

12.3.1.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers

12.3.2.  Opportunities in Europe

12.3.2.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers

12.3.2.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers

12.3.3.  Opportunities in Asia-Pacific and Rest of the World

12.3.3.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers

12.3.3.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers

13.        MARKET SIZING AND OPPORTUNITY ANALYSIS

13.1.     Chapter Overview

13.2.     Forecast Methodology and Key Assumptions

13.3.     Overall Prefilled Syringe Fill / Finish Services Market, 2020-2030

13.3.1.  Prefilled Syringe Fill / Finish Services Market: Distribution by Scale of Operation, 2020-2030

13.3.2.  Prefilled Syringe Fill / Finish Services Market: Distribution by Geographical Region

13.3.2.1. Prefilled Syringe Fill / Finish Services Market in North America

13.3.2.2. Prefilled Syringe Fill / Finish Services Market in Europe

13.3.2.3. Prefilled Syringe Fill / Finish Services Market in Asia-Pacific

13.3.2.4. Prefilled Syringe Fill / Finish Services Market Latin America

13.3.2.5. Prefilled Syringe Fill / Finish Services Market in Middle East and Africa

13.3.3.  Prefilled Syringe Fill / Finish Services Market: Distribution by Type of Drug Molecule, 2020-2030

13.3.4.  Prefilled Syringe Fill / Finish Services Market: Distribution by Therapeutic Area

13.3.5.  Prefilled Syringe Fill / Finish Services Market: Distribution by Syringe Barrel Material, 2020-2030

13.3.6.  Prefilled Syringe Fill / Finish Services Market: Distribution by Number of Barrel Chambers, 2020-2030

14.        FUTURE GROWTH OPPORTUNITIES

14.1.     Chapter Overview

14.2.     Growing Injectable Drugs Pipeline

14.3.     Increase in Popularity of Prefilled Syringes

14.4.     Rise in Preference for Outsourcing Fill / Finish Activities

14.5.     Advances in Aseptic Fill / Finish Technologies

14.6.     Growing Opportunities in the Asia-Pacific Region

15.        CASE STUDY: PREFILLED SYRINGE MANUFACTURERS

15.1.     Chapter Overview

15.2.     Prefilled Syringes: List of Available / Under Development Devices

15.2.1.  Analysis by Syringe Barrel Material

15.2.2.  Analysis by Number of Barrel Chambers

15.2.3.  Analysis by Type of Needle System

15.2.4.  Analysis by Barrel Volume

15.3.     Prefilled Syringes: List of Manufacturers

15.3.1.  Analysis by Year of Establishment

15.3.2.  Analysis by Location of Headquarters

16.        CONCLUDING REMARKS

16.1.     Chapter Overview

16.2.     Key Takeaways

17.        INTERVIEW TRANSCRIPTS

17.1.     Chapter Overview

17.2.     Bio Elpida

17.2.1.  Company Snapshot

17.2.2.  Interview Transcript: Gilles Devillers, President and Cofounder

17.3.     Intas Pharmaceuticals

17.3.1.  Company Snapshot

17.3.2.  Interview Transcript: Kirti Maheshwari, Chief Technical Officer

17.4.     IDT Biologika

17.4.1.  Company Snapshot

17.4.2.  Interview Transcript: Gregor Kawaletz, Chief Commercial Officer

17.5.     Takeda

17.5.1.  Company Snapshot

17.5.2.  Interview Transcript: Michael Dekner, Associate Director, Head of Process Sciences Formulation and Fill / Finish

17.6.     Synegene

17.6.1.  Company Snapshot

17.6.2.  Interview Transcript: Purushottam Singnurkar, Research Director and Head of Formulation Development

17.7.     IDEO

17.7.1.  Company Snapshot

17.7.2.  Interview Transcript: Jesse Fourt, Design Director

18.        APPENDIX 1: TABULATED DATA

19.        APPENDIX 2: LIST OF COMPANIES

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com